Trial NCT01028716

View at ClinicalTrials.gov 
Org. Study IDs: 2372.00
Secondary IDs: 2372 2372.00 NCI-2009-01433 RG9213052

Last trial update was posted on 2023-01-23

MeSH Interventions

Cyclophosphamide Fludarabine Fludarabine phosphate Lenograstim Mycophenolic Acid Tacrolimus

MeSH Conditions

Burkitt Lymphoma Hematologic Neoplasms Leukemia Leukemia, Biphenotypic, Acute Leukemia, Erythroblastic, Acute Leukemia, Lymphoid Leukemia, Myeloid Leukemia, Myeloid, Acute Lymphoma Lymphoma, Large-Cell, Anaplastic Lymphoma, Mantle-Cell Multiple Myeloma Myelodysplastic Syndromes Neoplasms, Plasma Cell Pathologic Complete Response Precursor Cell Lymphoblastic Leukemia-Lymphoma Preleukemia Recurrence Syndrome

Other Conditions

Acute Biphenotypic Leukemia Acute Erythroid Leukemia in Remission Acute Leukemia in Remission Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukaemia With Prior Myelodysplastic Syndrome Acute Myeloid Leukemia With FLT3/ITD Mutation Acute Myeloid Leukemia With Inv(3)(Q21Q26.2); RPN1-EVI1 Acute Myeloid Leukemia With Multilineage Dysplasia Acute Myeloid Leukemia With t(6;9) Acute Myeloid Leukemia in Remission Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia With T(1;19)(Q23;P13.3); E2A-PBX1 (TCF3-PBX1) Blasts Under 5 Percent of Bone Marrow Nucleated Cells Childhood Acute Lymphoblastic Leukemia in Complete Remission DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Hematopoietic Cell Transplant Recipient Myelodysplastic Syndrome Ph+ ALL Recurrent Anaplastic Large Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma Secondary Acute Myeloid Leukemia T Lymphoblastic Lymphoma

Stopping Reasons

The study experienced lower accrual rates after the onset of COVID. Upon review of the collected data it was deemed that an adequate amount of subjects has been enrolled to date to assess study aims.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID